Completed

Phase 3
Age: 18Years - 62Years
MALE
NCT00000512

Familial Atherosclerosis Treatment Study

Led by University of Washington · Updated on 2015-12-03

146

Participants Needed

N/A

Research Sites

291 weeks

Total Duration

On this page

Sponsors

U

University of Washington

Lead Sponsor

N

National Heart, Lung, and Blood Institute (NHLBI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

To compare the effects of two intensive lipid-lowering regimens with conventional therapy on coronary atherosclerosis as assessed by arteriography.

CONDITIONS

Official Title

Familial Atherosclerosis Treatment Study

Who Can Participate

Age: 18Years - 62Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Men
  • Age 62 or younger
  • elevated apolipoprotein B levels
  • coronary atherosclerosis
  • family history of coronary heart disease.
Not Eligible

You will not qualify if you...

  • diabetes
  • severe hypertension
  • cancer
  • liver disease
  • thyroid disease
  • kidney disease

Trial Site Locations

Site Locations not provided

Location information for this trial is currently unavailable.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here